Oncology & Cancer

US approves new drug against skin cancer

A breakthrough drug that could extend survival in some patients with advanced skin cancer was approved on Wednesday by US regulators, offering the first new treatment for melanoma in 13 years.

Oncology & Cancer

Study finds older people underestimate risk of deadly melanoma

New Zealanders aged 60 and over appear to wrongly believe they are at low risk of the fatal form of skin cancer melanoma, according to a new University of Otago study conducted for the Cancer Society of New Zealand.

Oncology & Cancer

Targeting PTEN may prevent skin cancer

Scientists believe they have identified a role for PTEN, a known tumor suppressor, in removing DNA damage derived from UVB radiation, a known risk factor for non-melanoma skin cancer, according to a study published in Cancer ...

Oncology & Cancer

Researchers identify key role of microRNAs in melanoma metastasis

Researchers at the NYU Cancer Institute, an NCI-designated cancer center at NYU Langone Medical Center, identified for the first time the key role specific microRNAs (miRNAs) play in melanoma metastasis to simultaneously ...

page 27 from 39